News Focus
News Focus
icon url

north40000

02/24/22 10:21 PM

#371674 RE: biopa #371670

Might look at MP too. Sales and earnings beat estimates per earnings call today; it’s a U.S.-based company. Closed ~ $43.85, + 7.37%. See also ATNM.

Cramer’s investment club site needs to be made aware of last week’s JAMA Network Open further review by MedStar of Amarin’s Reduce-It trial of Vascepa and its projected life-time patient benefit. FWIW, Cramer thinks XBI action is a foretell of biotech bottom today. Our portfolios, largely biotech, were + 4% today, a bit better than gain seen in the Nasdaq composite.
icon url

Jasbg

02/25/22 5:54 AM

#371683 RE: biopa #371670

biopa - north, I prefer ETFs where possible (spread - low expenses):

Had a look a Rare Metals options - and found nice list:

https://etfdb.com/index/sp-custom-precious-metals-and-mining-index/

No ETFs in this group though - REMX seems to be maybe the only ETF in this exact market.
icon url

Invest83838

02/25/22 6:21 AM

#371684 RE: biopa #371670

Totally Agree Biopa

As you know, rare earths are key to military weapons

I agree with you that Lynas in Australia may be a good investment for the long run

I also agree with North that MP, in the USA, may be a good investment for the long run

Since at some point China may start withholding rare earths from the USA and rest of the world

Rare Earths is another way China has the rest of the countries by the balls